Liraglutide and Renal Outcomes in Type 2 Diabetes
N Engl J Med
.
2017 Nov 30;377(22):2197-2198.
doi: 10.1056/NEJMc1713042.
Authors
Johannes F E Mann
1
,
David D Ørsted
2
,
John B Buse
3
Affiliations
1
KfH Kidney Center, Munich, Germany prof.j.mann@gmail.com
2
Novo Nordisk, Bagsvaerd, Denmark
3
University of North Carolina School of Medicine, Chapel Hill, NC
PMID:
29171823
DOI:
10.1056/NEJMc1713042
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 2*
Glucagon-Like Peptide 1
Humans
Hypoglycemic Agents
Kidney
Liraglutide*
Substances
Hypoglycemic Agents
Liraglutide
Glucagon-Like Peptide 1